Back
Stoke Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
STOK
Stoke Therapeutics, Inc.
Last Price:
$36.73
Seasonality Move:
15.92%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.
Stoke Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 33.01 | Buy |
| 50-day SMA: | 32.04 | Buy |
| 200-day SMA: | 23.09 | Buy |
| 8-day EMA: | 30.71 | Buy |
| 20-day EMA: | 19.35 | Buy |
| 50-day EMA: | 9.58 | Buy |
| 200-day EMA: | 2.68 | Buy |
Stoke Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.89 | Buy |
| Relative Strength Index (14 RSI): | 65.49 | Buy |
| Chaikin Money Flow: | 519520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Stoke Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Stoke Therapeutics, Inc. Stock
Is Stoke Therapeutics, Inc. Stock a Buy?
-
Stoke Therapeutics, Inc. share price is 36.41 while STOK 8-day simple moving average is 34.85, which is a Buy signal.
-
The stock price of STOK is 36.41 while Stoke Therapeutics, Inc. 20-day SMA is 33.01, which makes it a Buy.
-
Stoke Therapeutics, Inc. 50-day simple moving average is 32.04 while STOK share price is 36.41, making it a Buy technically.
-
STOK stock price is 36.41 and Stoke Therapeutics, Inc. 200-day simple moving average is 23.09, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Buy
58
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. a Buy or a Sell?
-
Stoke Therapeutics, Inc. stock is rated a BuyThe current Stoke Therapeutics, Inc. [STOK] share price is $36.41. The Score for STOK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Stoke Therapeutics, Inc. Stock Info
Market Cap:
2.1B
Price in USD:
36.41
Share Volume:
653.6K
Stoke Therapeutics, Inc. 52-Week Range
52-Week High:
38.69
52-Week Low:
5.35
Buy
58
Stoke Therapeutics, Inc. (STOK)
is a Buy
Stoke Therapeutics, Inc. Share Price Forecast
-
What is the Stoke Therapeutics, Inc. stock price today?The Stoke Therapeutics, Inc. stock price is 36.41 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics, Inc. is not overvalued.
Is Stoke Therapeutics, Inc. Stock a Buy?
-
Stoke Therapeutics, Inc. share price is 36.41 while STOK 8-day exponential moving average is 30.71, which is a Buy signal.
-
The stock price of STOK is 36.41 while Stoke Therapeutics, Inc. 20-day EMA is 19.35, which makes it a Buy.
-
Stoke Therapeutics, Inc. 50-day exponential moving average is 9.58 while STOK share price is 36.41, making it a Buy technically.
-
STOK stock price is 36.41 and Stoke Therapeutics, Inc. 200-day simple moving average is 2.68, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics, Inc.
Is Stoke Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.25 per share, and an increase next year of $0.42 per share.
Technical Analysis of Stoke Therapeutics, Inc.
Should I short Stoke Therapeutics, Inc. stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is 9.89, suggesting Stoke Therapeutics, Inc. is a Buy
-
Stoke Therapeutics, Inc. Relative Strength Index (RSI) is 65.49, which suggest Stoke Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Stoke Therapeutics, Inc. is ( - ), which suggest Stoke Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics, Inc. is ( - ), which suggest Stoke Therapeutics, Inc. is a Buy
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.